|Slideshows|September 17, 2018

A Rare Genetic Disorder That Causes Episodes of Flaccid Paralysis

About 30% of patients with periodic paralysis have unknown genetic mutation, making identification and treatment a challenge. Here: key points on genetics, testing, and subtypes of PPP.

Newsletter

Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.

Subscribe Now!

Related Content

Key Considerations in Treatment of Spinal Muscular Atrophy / Considerações essenciais para o tratamento da atrofia muscular espinhal

ByJohn F. Brandsema, MD,Marcelo Kerstenetzky, MD,Rodrigo de Holanda Mendonça, MD,Juliana Gurgel-Giannetti, PhD,Adriana Banzzatto Ortega, MD

March 2nd 2023

Rare Diseases Awareness and Educational Needs / Conscientização sobre doenças raras e necessidades educacionais

ByJohn F. Brandsema, MD,Marcelo Kerstenetzky, MD,Rodrigo de Holanda Mendonça, MD,Juliana Gurgel-Giannetti, PhD,Adriana Banzzatto Ortega, MD

March 2nd 2023

Spinal Muscular Atrophy Resources for Clinicians and Families / Recursos sobre atrofia muscular espinhal para profissionais de saúde e familiares

ByJohn F. Brandsema, MD,Marcelo Kerstenetzky, MD,Rodrigo de Holanda Mendonça, MD,Juliana Gurgel-Giannetti, PhD,Adriana Banzzatto Ortega, MD

March 2nd 2023

Access to Clinical Trials for Spinal Muscular Atrophy in Brazil / Acesso a testes clínicos para atrofia muscular espinhal no Brasil

ByJohn F. Brandsema, MD,Marcelo Kerstenetzky, MD,Rodrigo de Holanda Mendonça, MD,Juliana Gurgel-Giannetti, PhD,Adriana Banzzatto Ortega, MD

February 23rd 2023

Challenges in Spinal Muscular Atrophy Monitoring, Management and Access to Care in Brazil / Desafios no monitoramento da atrofia muscular espinhal, manejo e acesso a atendimento de saúde no Brasil

ByJohn F. Brandsema, MD,Marcelo Kerstenetzky, MD,Rodrigo de Holanda Mendonça, MD,Juliana Gurgel-Giannetti, PhD,Adriana Banzzatto Ortega, MD

February 23rd 2023

Latest CME

Video

From Suspicion to Stabilization: Early Recognition and Treatment of Paraneoplastic LEMS

Charu Aggarwal, MD, MPH, FASCO; Erminia Massarelli, MD, PhD, MS; Ruham Nasany, MD

Video

A Breath of Strength: Managing Cancer Associated LEMS and Lung Cancer as One

Estelamari Rodriguez, MD, MPH; Millie Das, MD; Ruham Nasany, MD

Video

Striking the Right Nerve: Managing Cancer Associated LEMS in Lung Cancer Patients

Anne Chiang, MD, PhD; J. Douglas Miles, MD, PhD, FAAN; Suma Satti, MD

Video

Patient, Provider, and Caregiver Connection: Improving Diagnosis and Care for Adolescent Myasthenia Gravis Patients – A New Frontier

Abigail N. Schwaede, MD; Emmanuelle (Noelle) Tiongson, MD

Video

A New Era in NMOSD Treatment: Optimizing Therapeutic Transitions and Reducing Patient Burden

Shamik Bhattacharyya, MD, MS, FAAN; Mirla Avila, MD; Dean Wingerchuk, MD

Audio

PER Podcast™: Maximizing the Multidisciplinary Care Outcomes of Patients with Amyotrophic Lateral Sclerosis (ALS)

Richard Bedlack, MD, PhD

Audio

PER Podcast™: Best Strategies for Approaching the Diagnosis of Amyotrophic Lateral Sclerosis (ALS)

Terry Heiman-Patterson, MD

Video

PER Postgame™: Updates from ANNA in the Management of IgA Nephropathy

Gerald Bernard Appel, MD; Ellie Kelepouris, MD, FACP, FAHA

Video

Patient, Provider, and Caregiver Connection: Turning a New Leaf in Acute Pain Management – How Recent Advancements Impact the Treatment Paradigm

Jeffrey Gudin, MD; Jeffrey Bettinger, PharmD

Multimedia

Shining a Light on an Ultra-Rare Disease – A Closer Look at Thymidine Kinase 2 Deficiency (TK2d)

Zarazuela Zolkipli-Cunningham, MBChB, MRCP; Mary Kay Koenig, MD; Perry Shieh, MD, PhD, FAAN, FANA

Video

Identifying and Treating Generalized Myasthenia Gravis in the Modern Era

James F. Howard Jr, MD, FAAN

Video

Addressing Unmet Needs for Patients With Spinal Muscular Atrophy—Understanding Patient Challenges and Management Approaches

Basil T. Darras, MD

Video

Rewiring Recovery: Evidence-Based Approaches to Managing Chronic Inflammatory Demyelinating Polyneuropathy

Karissa Gable, MD

Video

Expert Illustrations & Commentaries™: Visualizing the Role of Dystrophin Dysregulation as a Therapeutic Target in Duchenne Muscular Dystrophy and MD STARnet

Anne M. Connolly, MD, FAAN; Amy Moore, PhD

Video

Putting the Patient First in Acute Pain Management: The PA’s Guide to Incorporating Cutting-Edge Science Into Their Treatment Strategies

Jessica Oswald, MD, MPH; Jeremy A. Adler, DMSc, PA-C; Amanda Nasser, MS, NP

Video

Expert Illustrations & Commentaries™: Visualizing the Role of B Cells as Therapeutic Targets for Generalized Myasthenia Gravis

James F. Howard Jr, MD, FAAN; Katherine Ruzhansky, MD, MS

A Rare Genetic Disorder That Causes Episodes of Flaccid Paralysis

Newsletter

Related Content

Key Considerations in Treatment of Spinal Muscular Atrophy / Considerações essenciais para o tratamento da atrofia muscular espinhal

Rare Diseases Awareness and Educational Needs / Conscientização sobre doenças raras e necessidades educacionais

Spinal Muscular Atrophy Resources for Clinicians and Families / Recursos sobre atrofia muscular espinhal para profissionais de saúde e familiares

Access to Clinical Trials for Spinal Muscular Atrophy in Brazil / Acesso a testes clínicos para atrofia muscular espinhal no Brasil

Challenges in Spinal Muscular Atrophy Monitoring, Management and Access to Care in Brazil / Desafios no monitoramento da atrofia muscular espinhal, manejo e acesso a atendimento de saúde no Brasil

Latest CME

From Suspicion to Stabilization: Early Recognition and Treatment of Paraneoplastic LEMS

A Breath of Strength: Managing Cancer Associated LEMS and Lung Cancer as One

Striking the Right Nerve: Managing Cancer Associated LEMS in Lung Cancer Patients

Patient, Provider, and Caregiver Connection: Improving Diagnosis and Care for Adolescent Myasthenia Gravis Patients – A New Frontier

A New Era in NMOSD Treatment: Optimizing Therapeutic Transitions and Reducing Patient Burden

PER Podcast™: Maximizing the Multidisciplinary Care Outcomes of Patients with Amyotrophic Lateral Sclerosis (ALS)

PER Podcast™: Best Strategies for Approaching the Diagnosis of Amyotrophic Lateral Sclerosis (ALS)

PER Postgame™: Updates from ANNA in the Management of IgA Nephropathy

Patient, Provider, and Caregiver Connection: Turning a New Leaf in Acute Pain Management – How Recent Advancements Impact the Treatment Paradigm

Shining a Light on an Ultra-Rare Disease – A Closer Look at Thymidine Kinase 2 Deficiency (TK2d)

Identifying and Treating Generalized Myasthenia Gravis in the Modern Era

Addressing Unmet Needs for Patients With Spinal Muscular Atrophy—Understanding Patient Challenges and Management Approaches

Rewiring Recovery: Evidence-Based Approaches to Managing Chronic Inflammatory Demyelinating Polyneuropathy

Expert Illustrations & Commentaries™: Visualizing the Role of Dystrophin Dysregulation as a Therapeutic Target in Duchenne Muscular Dystrophy and MD STARnet

Putting the Patient First in Acute Pain Management: The PA’s Guide to Incorporating Cutting-Edge Science Into Their Treatment Strategies

Expert Illustrations & Commentaries™: Visualizing the Role of B Cells as Therapeutic Targets for Generalized Myasthenia Gravis

Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights

Remyelinating Agent PIPE-307 Falls Short in Phase 2 Trial of Relapsing Multiple Sclerosis

Brain-Penetrant Molecule GT-02287 Demonstrates Reversal of Glucosylsphinogosine in Parkinson Disease

Repositioning GLP-1 Drugs for Neurologic Disease: Evidence, Advances, and Outlook

CAPN2-Targeting Agent AMX0114 Shows Safe Profile in Phase 1 LUMINA Trial of ALS

CMSC 2026: Looking Ahead to the 40th Annual Meeting of the Consortium of MS Centers